Benitec Biopharma (BNTC) Payables (2019 - 2025)

Benitec Biopharma has disclosed Payables across 7 years of filings, most recently posting $1.8 million for Q4 2025.

• Payables for Q4 2025 came in at $1.8 million, down 23.4% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.8 million (down 23.4% YoY), and the FY2025 annual result was $1.0 million, down 75.46% from the prior year.
• Payables came in at $1.8 million for Q4 2025 at Benitec Biopharma, up from $1.1 million in the prior quarter.
• In the past five years, Payables ranged from a high of $4.9 million in Q4 2023 to a low of $880000.0 in Q2 2021.
• The 5-year median for Payables is $2.0 million (2021), against an average of $2.4 million.
• Across the five-year window, Payables soared 448.17% in 2021 and tumbled 75.46% in 2025, its largest moves.
• Benitec Biopharma's Payables stood at $1.9 million in 2021, then slipped by 5.96% to $1.8 million in 2022, then jumped by 169.78% to $4.9 million in 2023, then slumped by 51.08% to $2.4 million in 2024, then decreased by 23.4% to $1.8 million in 2025.
• The last three Payables figures came in at $1.8 million (Q4 2025), $1.1 million (Q3 2025), and $1.0 million (Q2 2025), per Business Quant data.